Navigation Links
Wisconsin First State in Nation to Screen Newborns for 'Bubble Boy Disease'

The Jeffrey Modell Foundation drives initiative for SCID screening

MILWAUKEE, Jan. 3 /PRNewswire/ -- On Jan. 1, Wisconsin became the first state in the nation to screen all newborns for Severe Combined Immune Deficiency (SCID). Sometimes known as "Bubble Boy Disease," SCID is a genetic disorder that is fatal without early diagnosis and treatment. Babies diagnosed can be referred for potentially life-saving treatment.

The Wisconsin Department of Health and Family Services approved moving to phase two of the pilot screening program in which screening for SCID will be routine for all newborns in Wisconsin (estimated at 70,000 annually). The screening has been added to the current panel of 47 other tests that are given to newborns.

The pilot program began one year ago as a collaborative effort between the Wisconsin State Laboratory of Hygiene at the University of Wisconsin-Madison, Children's Hospital of Wisconsin in Milwaukee and the Jeffrey Modell Foundation. Phase one involved developing a procedure using residual, unidentified blood specimens from Wisconsin's nationally recognized newborn screening program.

"The collaboration between the State Laboratory and Children's Hospital has advanced Wisconsin's health care for newborns at a rapid pace. The outstanding dedication demonstrated by everyone involved is the reason we have progressed to the next phase at a record pace," said Ronald H. Laessig, PhD, emeritus director and professor of Population Health Sciences at the State Laboratory of Hygiene, UW-Madison.

"This complex disease can be cured with a bone marrow transplant if diagnosed early before serious infections develop. That is why the early detection and treatment of SCID through routine screening in newborns will save lives. The screening also will spare infants' repeated and prolonged hospitalizations and save millions of dollars in health care costs. We believe that the Wisconsin Newborn Screening Program will serve as a blueprint for newborn screening in other states, spurring testing to save the lives of infants throughout the nation," said Jack Routes, MD, medical director of Allergy and Clinical Immunology at Children's Hospital of Wisconsin.

The Jeffrey Modell Foundation and Children's Hospital are providing the initial funding for this multi-year pilot. The foundation is a non-profit organization established by Vicki and Fred Modell in memory of their son Jeffrey who died at age 15 from a Primary Immunodeficiency (PI). SCID is one of 140 PI diseases. The pilot, which continues through 2010, will evaluate the effectiveness and outcomes of early testing for SCID. Once the pilot reaches completion, investigators hope for a rapid acceptance of the screening nationwide.

"The workshop held just about a year ago generated results far beyond anyone's expectations. The Jeffrey Modell Foundation identified newborn screening of SCID as a primary focus of its efforts and has now created a unique federal, state and private collaboration. We are committed to their vision that all newborns will be screened for SCID in a system where true cases are identified promptly and treated effectively," said Dr. Robert Vogt of the Newborn Screening Branch of the CDC Division of Laboratory Sciences.

U.S. Congress weighs in

In a related development, Congress just passed the first federal legislation funding newborn screening for SCID. Under the program, states will be able to apply for grants from the Centers for Disease Control and Prevention to set up pilot programs specifically for the purpose of screening for SCID.

"These developments are moving faster than Vicki and I could have ever imagined," said Fred Modell, co-founder of the Jeffrey Modell Foundation. "We now have eight to 10 states considering a pilot program to screen for SCID. We have federal funding, and cooperation by the CDC and National Institutes of Health. The state of Wisconsin is leading the way with accurate screening protocols." Vicki Modell, Modell Foundation co-founder, added, "We are closer to that day when we will bring a family and their newborn baby to Washington and let our lawmakers know how they have directly saved the life of this baby and so many babies in the future. This is very exciting."

The Boy in the Bubble: About SCID

SCID is the most lethal version of all primary immunodeficiency diseases. It often is called "Boy in the Bubble" after the movie of the same name that starred John Travolta, the true story of a boy with SCID who died at age 12 after spending his life in a plastic bubble because he was so vulnerable to infection. SCID causes a defect in the white blood cells that helps protect the body from viruses, bacteria and fungi. Doctors know that SCID is the result of a mutation in one of at least 12 genes, and bone marrow transplants are presently the best treatment.

About Jeffrey Modell Foundation

The Jeffrey Modell Foundation (JMF) was established in 1987 by Vicki and Fred Modell, in memory of their son, Jeffrey, who died from complications of Primary Immunodeficiency at the age of 15. JMF is a multi-faceted global nonprofit foundation devoted to the early and precise diagnosis, meaningful treatments, and ultimately cures of PI, and is focused on physician education, public awareness, and clinical and basic research to better understand and treat these Immunodeficiencies. To date, there are 36 Jeffrey Modell Research and Diagnostic Centers in the U.S., Canada, Europe, Middle East, South America, and Asia. For more information please visit the JMF website at

About Children's Hospital of Wisconsin

Children's Hospital of Wisconsin, founded in 1894, is recognized as one of the leading pediatric health care centers in the United States. It is included on Child magazine's 10 Best Children's Hospitals list and is named by U.S. News and World Report as one of America's Best Children's Hospitals. Children's Hospital is the only freestanding Level I Trauma Center in the region that cares exclusively for children and adolescents. The hospital has been designated a Magnet hospital by the American Nurses Credentialing Center, a national honor that recognizes nursing excellence. Children's Hospital is the flagship member of Children's Hospital and Health System. The health system is able to fulfill its mission thanks in part to philanthropic gifts and support from members of the community. Private, independent and not-for- profit, the hospital serves children and families from Wisconsin, the Upper Peninsula of Michigan, northern Illinois and beyond. For more information, visit the Web site at

About the Wisconsin State Laboratory of Hygiene

The State Laboratory of Hygiene is Wisconsin's public health laboratory. It is a nationally and internationally recognized leader in the field of newborn screening. As part of the University of Wisconsin-Madison School of Medicine and Public Health, it has played an instrumental role in developing many innovations now routine in newborn screening programs. The State Laboratory was the first to develop and fully implement routine screening for cystic fibrosis coupled with a vigorous and effective "pre-crisis" treatment program. Children identified with a "positive" CF test now are routinely treated at children's hospitals in Milwaukee and Madison. Currently, 35 states have followed the Wisconsin lead and now screen for CF. For more information, visit the Web site at
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. John Routes

SOURCE Children's Hospital of Wisconsin
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Francks Compounding Lab Purchases Wisconsin Pharmacy
2. Medical College of Wisconsin study finds drug may limit radiation kidney damage in BMT patients
3. Medical College of Wisconsin receives FDA grant
4. Sonic Foundry to Host Wisconsin Lt. Governor Lawton in Raising Awareness for National Depression Screening Day
5. March of Dimes NICU Family Support(R) Programs Give Wisconsin Families Comfort and Information during a Crisis
6. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
7. Corazonas Launches First and Only Cholesterol-Reducing Potato Chips
8. Put Safety First During Winter Fun
9. Methodist Mansfield Celebrates First Year
10. AspenBio Outlines Steps for FDA 510(k) Clearance of AppyScore(TM), the First Blood-Based Screen/Triage Test for Human Appendicitis
11. First reputable book on the history of the Paralympic Movement
Post Your Comments:
(Date:1/19/2017)... ... January 19, 2017 , ... In 2009, Carol Bryan endured ... in severe facial disfiguration. After four frightening years of isolation and emotional and ... Center, who removed the substances in a partial facial transplant through eight surgeries. ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and staff members in 2017 who are passionate about making a difference in ... 1994 and headquartered in Tampa, UMA, a nonprofit healthcare educational institution, has more ...
(Date:1/19/2017)... ... January 19, 2017 , ... Tribble Insurance Agency, a family ... Virginia region, is inaugurating a charity event to honor Chad Phillip Dermyer, a local ... last year, Chad Phillip Dermyer and his fellow officers were conducting routine stops of ...
(Date:1/19/2017)... ... 19, 2017 , ... Creative messages to prevent distracted driving ... Impact Teen Drivers and California Casualty. Entries from students aged 14-22 can be ... $15,000 will be awarded for the best peer-to-peer messages sharing solutions to reckless ...
(Date:1/19/2017)... ... , ... Connecticut Dermatology Group (CDG) is proud and excited to welcome back ... Dr. Kim brings an extensive background in cutting-edge dermatology care and research to Connecticut’s ... back Dr. Kim to the CDG team” said President and Managing Partner Dr. Steven ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... and PUNE, India , January 18, ... Allied Market Research, titled, "Breast Imaging Technologies Market by Type: ... global breast imaging technologies market size was valued at $2,544 ... by 2022, growing at a CAGR of 8.4% from 2016 ... Europe together accounted for over three-fourths market ...
(Date:1/18/2017)... , Jan. 18, 2017   Regenicin, Inc. ... biotechnology company specializing in the development and commercialization of ... tissues and organs, recently reported the Company,s operating results ... 2017. As the Company described in its ... a year of substantial accomplishments. The Company,s contract laboratory ...
(Date:1/18/2017)... , Suiza, 18 de enero de 2017  Hoy, ... lanzaron Access Accelerated, una iniciativa global para avanzar el ... y atención en países de renta baja y baja-media ... alcanzado un punto de crisis, particularmente en países de ... 80 por ciento de las muertes relacionadas con NCD. ...
Breaking Medicine Technology: